These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 15146898

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The first potent and selective non-imidazole human histamine H4 receptor antagonists.
    Jablonowski JA, Grice CA, Chai W, Dvorak CA, Venable JD, Kwok AK, Ly KS, Wei J, Baker SM, Desai PJ, Jiang W, Wilson SJ, Thurmond RL, Karlsson L, Edwards JP, Lovenberg TW, Carruthers NI.
    J Med Chem; 2003 Sep 11; 46(19):3957-60. PubMed ID: 12954048
    [Abstract] [Full Text] [Related]

  • 23. Validation of a histamine H3 receptor model through structure-activity relationships for classical H3 antagonists.
    Lorenzi S, Mor M, Bordi F, Rivara S, Rivara M, Morini G, Bertoni S, Ballabeni V, Barocelli E, Plazzi PV.
    Bioorg Med Chem; 2005 Oct 01; 13(19):5647-57. PubMed ID: 16085419
    [Abstract] [Full Text] [Related]

  • 24. In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonists.
    Hancock AA, Diehl MS, Faghih R, Bush EN, Krueger KM, Krishna G, Miller TR, Wilcox DM, Nguyen P, Pratt JK, Cowart MD, Esbenshade TA, Jacobson PB.
    Basic Clin Pharmacol Toxicol; 2004 Sep 01; 95(3):144-52. PubMed ID: 15447739
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. D-alanine piperazine-amides: novel non-imidazole antagonists of the histamine H3 receptor.
    Faghih R, Phelan K, Esbenshade TA, Miller TR, Kang CH, Krueger KM, Yao BB, Fox GB, Bennani YL, Hancock AA.
    Inflamm Res; 2003 Apr 01; 52 Suppl 1():S47-8. PubMed ID: 12755406
    [No Abstract] [Full Text] [Related]

  • 31. Search for novel leads for histamine H3-receptor antagonists: amine derivatives.
    Stark H, Ligneau X, Lipp R, Arrang JM, Schwartz JC, Schunack W.
    Pharmazie; 1997 Jun 01; 52(6):419-23. PubMed ID: 9260265
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
    Watanabe M, Kazuta Y, Hayashi H, Yamada S, Matsuda A, Shuto S.
    J Med Chem; 2006 Sep 07; 49(18):5587-96. PubMed ID: 16942032
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats.
    Medhurst AD, Briggs MA, Bruton G, Calver AR, Chessell I, Crook B, Davis JB, Davis RP, Foley AG, Heslop T, Hirst WD, Medhurst SJ, Ociepka S, Ray A, Regan CM, Sargent B, Schogger J, Stean TO, Trail BK, Upton N, White T, Orlek B, Wilson DM.
    Biochem Pharmacol; 2007 Apr 15; 73(8):1182-94. PubMed ID: 17276409
    [Abstract] [Full Text] [Related]

  • 39. Dibasic non-imidazole histamine H3 receptor antagonists with a rigid biphenyl scaffold.
    Morini G, Comini M, Rivara M, Rivara S, Lorenzi S, Bordi F, Mor M, Flammini L, Bertoni S, Ballabeni V, Barocelli E, Plazzi PV.
    Bioorg Med Chem Lett; 2006 Aug 01; 16(15):4063-7. PubMed ID: 16713264
    [Abstract] [Full Text] [Related]

  • 40. Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold.
    Vaccaro WD, Sher R, Berlin M, Shih NY, Aslanian R, Schwerdt JH, McCormick KD, Piwinski JJ, West RE, Anthes JC, Williams SM, Wu RL, She HS, Rivelli MA, Mutter JC, Corboz MR, Hey JA, Favreau L.
    Bioorg Med Chem Lett; 2006 Jan 15; 16(2):395-9. PubMed ID: 16246552
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.